Results 91 to 100 of about 25,343 (258)

Arylbenzazepines Are Potent Modulators for the Delayed Rectifier K+ Channel: A Potential Mechanism for Their Neuroprotective Effects [PDF]

, 2010
(±) SKF83959, like many other arylbenzazepines, elicits powerful neuroprotection in vitro and in vivo. The neuroprotective action of the compound was found to partially depend on its D1-like dopamine receptor agonistic activity. The precise mechanism for
Bernhard, Eric J., Chen, Xue-Qin, Hu, Guo-Yuan, Jin, Guo-Zhang, Neumeyer, John Leopold, Zhang, Ao, Zhang, Jing, Zhen, Xuechu   +7 more
core   +1 more source

Investigating Sleep Concerns in Cervical Dystonia

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Heterogenous, small cohorts, and co‐occurrence of pain and psychiatric burden complicate understanding of sleep in dystonia. Objective To investigate sleep concerns in cervical dystonia (CD). Methods Longitudinal data from CD‐PROBE on subjects who were toxin‐naïve, new to practice, or without injections for at least 16 weeks were ...
Abhimanyu Mahajan, David Andrés González, Cynthia Comella   +2 more
wiley   +1 more source

Psychotropic Medications-Induced Tardive Dyskinesia and Associated Factors Among Patients with Mental Illness in Ethiopia

Clinical Pharmacology: Advances and Applications, 2020
Assefa Kumsa, Shimelis Girma, Bezaye Alemu, Liyew Agenagnew Department of Psychiatry, Faculty of Medical Science, Institute of Health, Jimma University, Jimma, EthiopiaCorrespondence: Liyew AgenagnewJimma University, 378, Jimma, EthiopiaTel +251 ...
Kumsa A, Girma S, Alemu B, Agenagnew L
doaj  

The Acute Brain Response to Levodopa Heralds Dyskinesias in Parkinson Disease [PDF]

, 2014
OBJECTIVE: In Parkinson disease (PD), long‐term treatment with the dopamine precursor levodopa gradually induces involuntary “dyskinesia” movements. The neural mechanisms underlying the emergence of levodopa‐induced dyskinesias in vivo are still poorly ...
Christensen, Mark S., Haagensen, Brian N., Herz, Damian M., Løkkegaard, Annemette, Madsen, Kristoffer Hougaard, Rowe, James B., Siebner, Hartwig R.   +6 more
core   +1 more source

Ocular Motor Abnormalities in Functional Neurological Disorder: A Video‐Oculography Study

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Functional neurological disorders (FND) can include various sensory, motor or cognitive symptoms. Eye movement recordings, measured through video‐oculography, could serve as biomarkers for characterizing these dysfunctions in FND.
Aude Sangare, Astrid de Liège, Bertrand Gaymard, Sophie Rivaud‐Péchoux, Cécilia Bonnet, Evžen Růžička, Jaromír May, Tereza Serranová, Francine Mesrati, Emmanuel Roze, Marie Vidailhet, Céline Louapre, Lionel Naccache, Béatrice Garcin   +13 more
wiley   +1 more source

Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease

Parkinson's Disease, 2012
L-DOPA, the most effective drug to treat motor symptoms of Parkinson's disease, causes abnormal involuntary movements, limiting its use in advanced stages of the disease.
Eunju Shin, Elisabetta Tronci, Manolo Carta   +2 more
doaj   +1 more source

Dyskinesia induced by phenytoin Discinesia induzida por fenitoína

Arquivos de Neuro-Psiquiatria, 1999
Phenytoin is an effective antiepileptic drug, although, it can be associated with many side effects, including dyskinesia. OBJECTIVE: To describe the clinical characteristics of phenytoin induced dyskinesia.
M. AUGUSTA MONTENEGRO, ANNA ELISA SCOTONI, FERNANDO CENDES   +2 more
doaj   +1 more source

DRD2/ANKK1 Taq1A (rs 1800497 C>T) genotypes are associated with susceptibility to second generation antipsychotic-induced akathisia [PDF]

, 2012
Although the advent of atypical, second-generation antipsychotics (SGAs) has resulted in reduced likelihood of akathisia, this adverse effect remains a problem.
Barnes, M., Burton, S. C., Connor, J. P., Heslop, K., Lawford, B. R., Morris, C. P., Noble, E. P., Nyst, P., Swagnell, C. D., Voisey, J., Young, R. M.   +10 more
core   +2 more sources

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease

Therapeutics and Clinical Risk Management, 2018
Vibhash D Sharma, Kelly E Lyons, Rajesh Pahwa Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA Abstract: Levodopa-induced dyskinesia (LID) is a common motor complication in patients with Parkinson’s disease on ...
Sharma VD, Lyons KE, Pahwa R
doaj  

Canine paroxysmal dyskinesia—a review

Frontiers in Veterinary Science
Paroxysmal dyskinesias (PDs) are a group of involuntary, hyperkinetic movement disorders that recur episodically and may last seconds to hours. An important feature of PD is that there is no loss of consciousness during the episode.
Paul J. J. Mandigers, Paul J. J. Mandigers, Koen M. Santifort, Koen M. Santifort, Koen M. Santifort, Mark Lowrie, Laurent Garosi   +6 more
doaj   +1 more source